Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:26 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 1,578 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Arrhythmias Cardiac Clear all

Conditions: Atrial Fibrillation
Interventions: CPM Device; Device
Lead sponsor: Analog Device, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 141 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Atrial Fibrillation, Hypertension
Interventions: AF ablation with Renal Denervation, AF ablation alone; Procedure
Lead sponsor: Siva Mulpuru; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Bradycardia, Heart Failure
Interventions: CRT-D Implantation, CRT-P Implantation, Dual Chamber Pacemaker Implantation; Procedure
Lead sponsor: Yong-Mei Cha; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Congenital Heart Disease, Bradycardia Sinus
Interventions: Closed loop stimulation, Standard rate response; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 14 Years to 65 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Atrial Fibrillation, Arrhythmia, Stroke, Cardiovascular
Interventions: The Lifestar Act III; Device
Lead sponsor: University of Miami; Other
Eligibility: 40 Years to 85 Years
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Atrial Fibrillation
Interventions: LARIAT + PVI, Pulmonary Vein Isolation; Device
Lead sponsor: AtriCure, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 53
States / cities: Phoenix, Arizona • La Jolla, California • Los Angeles, California + 44 more

Conditions: Atrial Fibrillation
Interventions: Enoxaparin; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2004
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cardiac Arrhythmia
Interventions: AleriTM sensors; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 100 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Atrial Fibrillation
Interventions: Not listed
Lead sponsor: Itamar-Medical, Israel; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 3
States / cities: New York, New York • Austin, Texas

Conditions: Atrial Fibrillation, Atrial Flutter
Interventions: Record and transmit heart rhythm; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Heart Failure, Implantable Defibrillator User, Ventricular Arrythmia
Interventions: Not listed
Lead sponsor: Larisa Tereshchenko; Other
Eligibility: 18 Years to 89 Years
Enrollment: 3,471 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 6
States / cities: Los Angeles, California • Stanford, California • Aurora, Colorado + 2 more

Conditions: Atrial Fibrillation
Interventions: (R)-propafenone, (S)-Propafenone, Placebo; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 193 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Atrial Fibrillation
Interventions: Dispersion ablation + PVI, VX1, PVI; Procedure · Device
Lead sponsor: Volta Medical; Industry
Eligibility: 18 Years and older
Enrollment: 377 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 8
States / cities: Birmingham, Alabama • Jacksonville, Florida • St Louis, Missouri + 5 more

Conditions: Heart Failure, Left Bundle-Branch Block
Interventions: Mapping and Pacing the His Bundle, Placing a guidewire in Coronary sinus for measurement of Q-LV during His Bundle pacing or, if needed, for LV pacing; Procedure
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Tachycardia, Ventricular
Interventions: Remifentanil; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Down Syndrome, Bradycardia
Interventions: Monitoring patients undergoing surgery to look for association between ANS activity and bradycardia; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 1 Month to 8 Years
Enrollment: 195 participants
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Persistent Atrial Fibrillation
Interventions: Catheter ablation, Mini-maze surgical procedure; Procedure
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Atrial Fibrillation
Interventions: active tVNS, sham tVNS; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 80 Years
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Los Angeles, California • Oklahoma City, Oklahoma

Conditions: Atrial Fibrillation, Atrial Flutter, Inflammation
Interventions: Not listed
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Atrial Fibrillation
Interventions: Non-Interventional; Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Ventricular Tachycardia
Interventions: Dantrolene/Ryanodex, Placebo; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Atrial Fibrillation
Interventions: dapagliflozin, Placebo; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 3
States / cities: Portland, Maine • Detroit, Michigan • Rochester, New York

Conditions: Paroxysmal Atrial Fibrillation
Interventions: PVI Ablation, FIRM Ablation; Procedure
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Device-Related Thrombosis, Atrial Fibrillation, Left Atrial Appendage Occlusion
Interventions: ASA plus Clopidogrel, Genetic-Tailored AntiThrombotic Strategy, Half-Dose of novel OAC; Drug
Lead sponsor: Texas Cardiac Arrhythmia Research Foundation; Other
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Austin, Texas

Search by objective public record fields.

ECG Validation Study

Renal Denervation Therapy in Hypertensive Patients Undergoing A-Fib Ablation

His Bundle Pacing in Bradycardia and Heart Failure

Specialized Pacing for Patients With Congenital Heart Disease

Arrhythmia Detection In Obstructive Sleep Apnea (ADIOS)

aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation

Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)

Measuring Hydration Levels of Healthy and Heart Failure Patients Before, During, and After an Electrophysiology (EP) Procedure

Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation?

Using Smart Phone Technology in Detecting the Presence of Atrial Fibrillation

Global Electrical Heterogeneity and Clinical Outcomes

New Formulations of Propafenone to Treat Atrial Fibrillation

Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation

Mapping and Pacing of the His Bundle for Heart Failure Patients With Left Bundle Branch Block

Remifentanil Intravenous Patient Controlled Analgesia (IVPCA) for Ablation of Idiopathic Ventricular Tachycardia

Down Syndrome Autonomic Nervous System Induction Bradycardia

Epicardial Mini-Maze Versus Catheter Ablation for the Management of Persistent Atrial Fibrillation

Transcutaneous (Tragus) Vagal Nerve Stimulation for Post-op Afib

Markers of Oxidative Stress Present in Left Atrial Appendage Tissue in Patients With Atrial Fibrillation

The Effect of Posterior Pericardiotomy on the Incidence of Atrial Fibrillation After Cardiac Surgery-Extended Follow-Up

A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.

Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation

Focal Impulse and Rotor Modulation Ablation Trial for Treatment of Paroxysmal Atrial Fibrillation (FIRMAT-PAF)

Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion